Background Lung cancer screening with low-dose chest CT (LDCT) reduces the mortality of
eligible individuals. Blood signatures might act as a standalone screening tool, refine the …

Early-stage treatment improves prognosis of lung cancer and two large randomized
controlled trials have shown that early detection with low-dose computed tomography (LDCT) …

Background Hypersensitivity reactions (HSRs) to platinum salts (PS) and taxanes (TX) are a
challenge to cancer management. Allergy evaluation based on skin tests (ST) and graded …

Molecular diagnosis of lung cancer is a constantly evolving field thanks to major advances
in precision oncology. The wide range of actionable molecular alterations in non-squamous …

Introduction Gene fusion testing of ALK, ROS1, RET, NTRK, and MET exon 14 skipping
mutations is guideline recommended in nonsquamous NSCLC (NS-NSCLC). Nevertheless, …

Introduction Both MET expression and the PD-L1 tumor proportion score (TPS) are companion
diagnostics for treatment of advanced non-small cell lung carcinoma (aNSCLC) patients. …

Background Management of large numbers of reverse transcriptase-polymerase chain
reactions (RT-PCR) for diagnosis of coronavirus 2019 disease (COVID-19) requires robust …

Introduction Patients with advanced-stage NSCLC whose tumors harbor an ALK gene
rearrangement benefit from treatment with multiple ALK inhibitors (ALKi). Approximately 30% of …

Background: Bronchoscopic lung volume reduction using endobronchial coils is a new treatment
for patients with severe emphysema. To date, the benefits have been modest and have …

Introduction International guidelines recommend BRAF mutational status assessment in
treatment-naive advanced non-squamous non-small cell lung carcinoma (NSCLC) patients …